AdaptHealth (AHCO) Cost of Revenue (2019 - 2026)

AdaptHealth has reported Cost of Revenue for 8 years, with the latest figure at $636.1 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 22.02% year-over-year to $636.1 million in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 7.64% increase from a year earlier, with the FY2025 full-year figure at $2.6 billion, up 2.16% from the prior year.
• Cost of Revenue was $636.1 million for Q2 2026 at AdaptHealth, down from $708.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $708.3 million in Q1 2026, with the low at $521.3 million in Q2 2025.
• Average Cost of Revenue over 5 years is $633.5 million, with a median of $645.3 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue soared 50.52% in 2022, then dropped 18.11% in 2025.
• Over 5 years, Cost of Revenue stood at $536.6 million in 2022, then rose by 3.2% to $553.8 million in 2023, then grew by 19.97% to $664.4 million in 2024, then increased by 1.46% to $674.1 million in 2025, then declined by 5.64% to $636.1 million in 2026.
• The last three Cost of Revenue figures came in at $636.1 million (Q2 2026), $708.3 million (Q1 2026), and $674.1 million (Q4 2025), per Business Quant data.